Avian Influenza Latest Advances

Protection Against HPAI-H5N8 Early Challenge in Commercial Broilers with Maternal Immunity: Prime-Boost vs. Single Vaccination of a Trivalent H5-Inactivated Vaccine.

Journal: Avian pathology : journal of the W.V.P.A

Published: December 15, 2025

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025.

Journal: Emerging microbes & infections

Published: December 15, 2025

Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.

Journal: Emerging infectious diseases

Published: December 12, 2025

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: December 12, 2025

Leveraging Systems-of-Systems Analysis to Strengthen Epidemic Intelligence for Preparedness and Response.

Journal: Health security

Published: December 10, 2025

Protecting pregnancy during pandemics: What recent outbreaks teach us.

Journal: Human vaccines & immunotherapeutics

Published: December 10, 2025

Avian influenza in the context of a pandemic challenge.

Journal: AIDS reviews

Published: December 10, 2025

Smartphone-assisted upconversion nanoparticle assay for rapid multiplex detection of H5, H7, and H10 avian influenza viruses.

Journal: Emerging microbes & infections

Published: December 09, 2025

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Journal: Antiviral therapy

Published: December 09, 2025

Clinical and epidemiological characteristics of four human cases of avian influenza virus infection in Zhejiang Province, China, 2021-2024.

Journal: Infectious diseases (London, England)

Published: December 09, 2025

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: December 05, 2025

Timely vaccine strain selection and genomic surveillance improve evolutionary forecast accuracy of seasonal influenza A/H3N2.

Journal: eLife

Published: December 04, 2025

Filters

Protection Against HPAI-H5N8 Early Challenge in Commercial Broilers with Maternal Immunity: Prime-Boost vs. Single Vaccination of a Trivalent H5-Inactivated Vaccine.

Protection Against HPAI-H5N8 Early Challenge in Commercial Broilers with Maternal Immunity: Prime-Boost vs. Single Vaccination of a Trivalent H5-Inactivated Vaccine.

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025.

Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025.

Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.

Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025.

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses.

Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses.

Leveraging Systems-of-Systems Analysis to Strengthen Epidemic Intelligence for Preparedness and Response.

Leveraging Systems-of-Systems Analysis to Strengthen Epidemic Intelligence for Preparedness and Response.

Protecting pregnancy during pandemics: What recent outbreaks teach us.

Protecting pregnancy during pandemics: What recent outbreaks teach us.

Avian influenza in the context of a pandemic challenge.

Avian influenza in the context of a pandemic challenge.

Smartphone-assisted upconversion nanoparticle assay for rapid multiplex detection of H5, H7, and H10 avian influenza viruses.

Smartphone-assisted upconversion nanoparticle assay for rapid multiplex detection of H5, H7, and H10 avian influenza viruses.

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Clinical and epidemiological characteristics of four human cases of avian influenza virus infection in Zhejiang Province, China, 2021-2024.

Clinical and epidemiological characteristics of four human cases of avian influenza virus infection in Zhejiang Province, China, 2021-2024.

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Timely vaccine strain selection and genomic surveillance improve evolutionary forecast accuracy of seasonal influenza A/H3N2.

Timely vaccine strain selection and genomic surveillance improve evolutionary forecast accuracy of seasonal influenza A/H3N2.